Biography
Alex Schnapp is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Alex participates in the representation of public and private companies in mergers, acquisitions and divestitures.
Alex has been part of the teams advising:
- Glencore, CPP Investments and BC, as shareholders, in Viterra Ltd.’s approximately $18 billion business combination with Bunge Ltd.
- Iron Mountain Incorporated in its acquisition of Regency Technologies
- Sanofi in its $2.9 billion acquisition of Provention Bio Inc. and its pending approximately $2.2 billion acquisition of Inhibrx, Inc.
Prior to joining Weil, Alex was a Corporate associate at another international law firm.
Alex received his J.D. from the Benjamin N. Cardozo School of Law and his B.A. from Duke University.